A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020.
A federal judge on Friday declined to block the Biden administration from implementing Medicare drug price negotiations, upholding for now a controversial process that aims to make costly medications more affordable for older Americans.
That date is the deadline for manufacturers of the first 10 drugs selected for negotiations to agree to participate in the talks.
Newman also gave the Biden administration until Oct. 27 to renew its motion to dismiss the case.
The ruling from Newman is a blow to the pharmaceutical industry, which views the process as a threat to its revenue growth, profits and drug innovation.
Persons:
Biden, Judge Michael Newman, Newman, Donald Trump, Joe Biden's, Johnson
Organizations:
Pfizer Pharmaceuticals, Southern, Southern District of Ohio, Chamber of Commerce, Chamber, Merck, Johnson
Locations:
Provo , Utah, Southern District